Committed to its goal of
making care available to all, Johnson & Johnson (Philippines), Inc. (J&J
Philippines) continues its support to organizations which provide healthcare
essentials to communities. The company’s most recent donation is of 3,000
bottles of Hexetidine Bactidol® oral
antiseptic to help alleviate sore throat for immediate protection in the new
normal, through the healthcare giant’s ongoing support to the Philippines Red
Cross for inclusion in their COVID-19 care kits to be distributed in
communities urgently in need.
“It’s been over two years and even
though our COVID-19 restrictions are now considerably lighter, it is undeniable
that we are still living and dealing with the pandemic. We want to continue with
the assistance we have been extending to ensure that fellow Filipinos stay
healthy,” said Chili Perez, sr. brand manager for Bactidol®. “And
so, it is our hope that these self-care essentials will help in a big way in staying
protected at all times.”
"The Philippine Red Cross
would like to thank J&J Philippines for their donation and their vote of
confidence towards the Philippine Red Cross. This donation will go a long way
towards providing quality life-saving services that protect life and dignity of
Filipinos in vulnerable situations” says Richard J. Gordon, Chairman and CEO of
the Philippine Red Cross.
At Johnson & Johnson,
we believe good health is the foundation of vibrant lives, thriving communities
and forward progress. That’s why for more than 130 years, we have aimed to keep
people well at every age and every stage of life. Today, as the world’s largest
and most broadly-based healthcare company, we are committed to using our reach
and size for good. We strive to improve access and affordability, create
healthier communities, and put a healthy mind, body and environment within
reach of everyone, everywhere. We are blending our heart, science, and
ingenuity to profoundly change the trajectory of health for humanity. Learn
more at www.jnj.com. Follow us at @JNJNews.
No comments:
Post a Comment